Columbia University College of Physicians and Surgeons and Med-IQ Present Key Findings Regarding the Treatment of Schizophrenia in a CME-Certified Activity

BALTIMORE, MD—October 2, 2014—Columbia University College of Physicians and Surgeons and Med-IQ, an award-winning, ACCME-accredited provider of continuing medical education (CME), are pleased to announce the availability of the CME-certified online activity, Myths and Realities Regarding the Use of Long-Acting Injectable Antipsychotics in Schizophrenia: Insights From the Frontline.

Preventing relapses in patients with schizophrenia is essential to improving their long-term outcomes. When used appropriately, long-acting injectable (LAI) antipsychotics can help minimize periods of treatment discontinuation. However, confusion regarding this therapeutic option sometimes exists among patients and healthcare professionals. This educational activity addresses this confusion and provides state-of-the-art evidence along with expert insight on the appropriate use of LAI antipsychotic agents in patients with schizophrenia.

“This online publication presents key findings and practice pearls from a series of 30-minute individualized teleconferences for psychiatrists,” said John Lauriello, MD, professor and chairman of the University of Missouri Department of Psychiatry in Columbia, MO. “It also discusses myths and realities regarding the use of LAIs in the treatment of patients with schizophrenia.”

Clinicians are invited to visit www.Med-IQ.com/a767 for complimentary access to this educational opportunity. For more information, please call (toll-free) 866 858 7434 or e-mail info@med-iq.com.

The College of Physicians and Surgeons of Columbia University is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The College of Physicians and Surgeons designates this enduring material for 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity is supported by an educational grant from Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC.

About Med-IQ

Med-IQ, America's most respected provider of continuing medical education (CME), inspires healthcare professionals through award-winning activities that deliver sophisticated outcomes-based educational designs with measurable results in professional competence and performance. Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the California Board of Registered Nursing (CBRN), and the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing medical education to physicians, nurses, and pharmacists, respectively.

Med-IQ, a leader in the development of performance improvement (PI) and quality improvement (QI) CME initiatives, has been recognized by the Alliance for Continuing Education in the Health Professions for our excellence in CE research (William Campbell Felch Award 2013, 2011), educational collaborations (2013), outstanding CME outcomes assessment (2012), and exceptional leadership (Leadership Award 2013, President’s Award 2012). To learn more about Med-IQ, visit www.Med-IQ.com, like us on Facebook, follow us on Twitter, and connect with us on LinkedIn.

For more information, contact:

Amy Caswell
Senior Audience Development Manager
866 858 7434
info@med-iq.com


Med-IQ.
Inspiring Medical Education.